Intriguingly, circulating CD4+ T cells and CD4+CD25hi Treg of HNSCC patients including patients that had received RT as part of multimodal treatment displayed up-regulated expression of CD39 and hydrolyzed ATP at higher rates and produced higher levels of adenosine than normal controls’ Treg. This evidence concerns the gene CD4 and head and neck squamous cell carcinoma.